tiprankstipranks
Plus Therapeutics Inc (DE:XMPA)
FRANKFURT:XMPA

Plus Therapeutics (XMPA) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Plus Therapeutics Inc’s (XMPA) Moving Averages Convergence Divergence (MACD) indicator is -0.29, suggesting Plus Therapeutics Inc is a Buy.
Plus Therapeutics Inc’s (XMPA) 20-Day exponential moving average is 3.46, while Plus Therapeutics Inc’s (XMPA) share price is €2.763, making it a Sell.
Plus Therapeutics Inc’s (XMPA) 50-Day exponential moving average is 3.98, while Plus Therapeutics Inc’s (XMPA) share price is €2.763, making it a Sell.

Plus Therapeutics (XMPA) Pivot Points

May 05, 2024, 09:29 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.92
2.34
2.55
2.97
3.18
3.60
3.81
Fibonacci
2.34
2.58
2.73
2.97
3.21
3.36
3.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Plus Therapeutics (XMPA) Moving Averages

May 05, 2024, 09:29 AM
Period
Simple
Exponential
MA5
2.99Sell
3.00Sell
MA10
3.39Sell
3.23Sell
MA20
3.53Sell
3.46Sell
MA50
4.03Sell
3.98Sell
MA100
4.63Sell
4.66Sell
MA200
6.35Sell
5.92Sell
Plus Therapeutics Inc’s (XMPA) 10-Day exponential moving average is 3.23, while Plus Therapeutics Inc’s (XMPA) share price is €2.763, making it a Sell.
Plus Therapeutics Inc’s (XMPA) 100-Day exponential moving average is 4.66, while Plus Therapeutics Inc’s (XMPA) share price is €2.763, making it a Sell.
Plus Therapeutics Inc’s (XMPA) stock price is €2.763 and Plus Therapeutics Inc’s (XMPA) 50-day simple moving average is 4.03, creating a Sell signal.
Plus Therapeutics Inc’s (XMPA) stock price is €2.763 and Plus Therapeutics Inc’s (XMPA) 100-day simple moving average is 4.63, creating a Sell signal.
Plus Therapeutics Inc’s (XMPA) stock price is €2.763 and Plus Therapeutics Inc’s (XMPA) 200-day simple moving average is 6.35, creating a Sell signal.

Plus Therapeutics (XMPA) Technical Indicators

May 05, 2024, 09:29 AM
Name
Value
Implied Action
RSI (14)
28.43
Buy
STOCH (9,6)
>-0.01
Buy
STOCHRSI (14)
>-0.01
Buy
MACD (12,26)
-0.29
Buy
ADX (14)
23.28
Neutral
Williams %R
-100.00
Buy
CCI (14)
-141.56
Buy
ATR (14)
0.24
-
Ultimate Oscillator
14.18
Sell
ROC
-24.20
Sell
Plus Therapeutics Inc’s (XMPA) Relative Strength Index (RSI) is 28.43, creating a Buy signal.
Plus Therapeutics Inc’s (XMPA) Trend Strength Indicator (ADX) is 23.28, creating a Neutral signal.
Plus Therapeutics Inc’s (XMPA) Commodity Channel Index (CCI) is -141.56, creating a Buy signal.
Plus Therapeutics Inc’s (XMPA) Price Rate of Change (ROC) is -24.20, creating a Sell signal.

FAQ

Is XMPA a Buy, Hold, or Sell?
Based on XMPA’s technical indicators, XMPA is a Sell.
    What is XMPA’s RSI (14)?
    XMPA’s RSI (14) is 28.43, which suggests XMPA is a Buy.
      What is XMPA’s MACD?
      XMPA’s MACD is -0.29, which suggests XMPA is a Buy.
        What is XMPA’s 5-day moving average?
        XMPA’s 5-day moving average is 2.99, which suggests XMPA is a Sell.
          What is XMPA’s 20-day moving average?
          XMPA 20-day moving average is 3.53, which suggests XMPA is a Sell.
            What is XMPA’s 50-day moving average?
            XMPA’s 50-day moving average is 4.03, which suggests XMPA is a Sell.
              What is XMPA’s 200-day moving average?
              XMPA’s 200-day moving average is 6.35, which suggests XMPA is a Sell.
                What is XMPA’s Williams % R (14)?
                XMPA’s Williams % R (14) is -100.00, which suggests XMPA is a Buy.
                  What is XMPA’s CCI (14)?
                  XMPA’s CCI (14) is -141.56, which suggests XMPA is a Buy.
                    What is the share price of Plus Therapeutics Inc?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis